By Maria Armental
Storage and information management company Iron Mountain Inc. said its board has approved the company's conversion to a real-estate investment trust, following a favorable ruling from the U.S. Internal Revenue Service.
By Carla Mozee, MarketWatch
LONDON (MarketWatch) -- Futures for U.S. stocks were listless Thursday, as Wall Street waited for figures on consumer spending, personal income and a weekly update on claims for unemployment benefits.
SAN DIEGO, June 26, 2014 (GLOBE NEWSWIRE) -- Royale Energy, Inc. (Nasdaq:ROYL) today announced the results of an independent review of the prospective resource potential of two recently identified North Slope Alaska drilling targets.
NEW YORK , June 26, 2014 /PRNewswire/ -- Mortgage rates were down for the second week in a row, with the benchmark 30-year fixed mortgage rate sliding to 4.28 percent, according to Bankrate.com's weekly national survey.
Empire Company Reports Fiscal 2014 Fourth Quarter and Full Year Results Canada NewsWire
(1) Amounts have been restated as a result of a change in accounting policy
and reclassification of discontinued operations.
Hampton Inn & Suites and Homewood Suites by Hilton property added to portfolio NEW YORK , June 26, 2014 /PRNewswire/ -- Carey Watermark Investors Incorporated (CWI), a non-traded real estate investment trust (REIT) focused on investing in lodging properties, announced that it has acquired a 302-room, dual-brand select-service hotel, located in Denver's Central Business District.
Energy Transfer Partners, L.P. (NYSE: ETP) today announced that its
Board of Directors has approved building a pipeline to transport natural
gas from processing facilities located in the prolific Marcellus and
Utica Shale areas to numerous market regions in the United States and
Watsco, Inc. (NYSE:WSO) (PARIS:WSO) announced today that it has
refinanced its existing unsecured revolving credit agreement led by
JPMorgan Chase Bank as Administrative Agent, Bank of America and Wells
Fargo Bank as Co-Syndication Agents and U.S. Bank National Association
as Documentation Agent.
(Corrects to remove adjusted EPS number that was from the year earlier) NEW YORK (MarketWatch) -- Accenture (ACN) said Thursday it had net income of $881.8 million, or $1.26 a share, in its fiscal third quarter, up from $874.1 million, or $1.21, in the same period a year ago.
NEW YORK (MarketWatch) -- Accenture (ACN) said Thursday it had net income of $881.8 million, or $1.26 a share, in its fiscal third quarter, up from $874.1 million, or $1.21, in the same period a year ago.
Accenture (NYSE:ACN) reported strong financial results for the third
quarter of fiscal 2014, ended May 31, 2014, with net revenues of
$7.74 billion, an increase of 7 percent in both U.S. dollars and local
currency over the same period last year, above the company’s guided
range of $7.40 billion to $7.65 billion.
SAN DIEGO, Calif., June 26, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Cubic Corporation (NYSE:CUB) announced that effective July 1, Bill Toti will succeed Jimmie Balentine as president of Cubic's Mission Support Services segment.
LONDON, Ky., June 26, 2014 (GLOBE NEWSWIRE) -- Puissant Industries, Inc. (OTCBB:PSSS) (the "Company"), an independent energy company currently focused on the natural gas and liquids rich portion of the Devonian shale play in Eastern Kentucky, announced today that its acquisition of additional proven natural gas and oil reserves reports 1.180 billion cubic feet (Bcf) of natural gas and .111 million barrels of oil, representing a total increase of .3081 million barrels of oil equivalent (BOE) (1Bbl – 6 Mcf basis), based on an independent engineering report as of March 1, 2014, The Company's BOE at March 1, 2014 represents a 9.6% increase from the December 31, 2013 engineering report.
Top-line results anticipated by end-of-year First potential topical product for painful diabetic neuropathy RALEIGH, N.C. , June 26, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has completed enrollment of all patients required for its initial Phase 3 study of Clonidine Topical Gel for the treatment of painful diabetic neuropathy (PDN).
The Phase 3 trial is a multicenter, randomized, double-blind, placebo-controlled study to determine the efficacy and safety of Clonidine Topical Gel in the treatment of pain associated with PDN.
Cracker Jack Brand Brings the Magic of Surprise to Families across America with the Launch of 'The Surprise Inside Project' PLANO, Texas , June 26, 2014 /PRNewswire/ -- Who doesn't love a great surprise?
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.